FORM Life Ventures

A venture capital firm dedicated to funding and incubating science-driven longevity companies. Their mission is to drive a new era in healthcare by proactively empowering health through early and personalized care to prevent disease and extend healthy lifespan. They believe that hard-nosed science will shape the future of healthcare by accelerating data-driven breakthroughs.

They invest in seed-stage companies within the healthcare, cannabis, and personal health industries, focusing on New York and Los Angeles in the United States. Their investment areas include health tech, health & wellness, and digital health. They typically invest between $500,000 and $2 million.

Their portfolio includes companies such as Vero, pioneering proteomics for precision organ health; People Science, a collaborative effort to democratize science; Teal, an advanced proteomics analytics platform; RxDiet, reimagining food as medicine; and Indomo, revolutionizing acne care for a clearer tomorrow. Their team includes Founding Partner Markus Okumus, Scientific Founder Prof. Tony Wyss-Coray, and Associate/IR Vahik Soghom.